• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

监测运动方案对肝硬化和门静脉高压症患者脑血流和肝血流动力学的影响。

Effect of a monitored exercise protocol in cerebral and hepatic hemodynamics in patients with cirrhosis and portal hypertension.

机构信息

Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Liver fibrosis and Nutrition Lab (LFN-Lab), Mexico City, Mexico; MICTLAN-Network, Mexico City, Mexico.

Department of Gastroenterology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Liver fibrosis and Nutrition Lab (LFN-Lab), Mexico City, Mexico; MICTLAN-Network, Mexico City, Mexico.

出版信息

Dig Liver Dis. 2024 May;56(5):827-835. doi: 10.1016/j.dld.2023.11.011. Epub 2023 Nov 25.

DOI:10.1016/j.dld.2023.11.011
PMID:38008698
Abstract

BACKGROUND

Physical exercise (PE) has been proven to be beneficial in patients with cirrhosis; effects in cognitive function and cerebral hemodynamics, are yet to be explored.

AIM

To evaluate the effects of a PE program (LFN-exercise protocol) in hepatic/cerebral hemodynamics.

METHODS

Randomized open clinical trial in patients with cirrhosis; Control: Diet(n = 13),Intervention: Diet + exercise(n = 14) for 12 weeks. Patients received an educational session, mental exercises (printed book and sudoku), and high-protein diet. Exercise intervention consisted of walking 4 times/week with an intensity rated between 12 and 14 on the Borg scale, monitored through bracelet accelerometers. Patients received weekly text messages to encourage adherence and had monthly in-person visits.

RESULTS

Patients were mainly Child-Pugh A(88.9 %), median MELD 8(8-10), mean age 53±8 years. In the exercise group the number of steps increased from 9667±3008 to 11,931±4463 (p = 0.002), vs 8004±3224 to 8903±3504 (p = 0.053) in controls. Exercise decreased HVPG from 11(8-14) to 8(6-11)mmHg (p = 0.032) vs no change in the control group from 14(12-16) to 15(11-17)mmHg (p = 0.959). Intervention group showed better cerebral hemodynamics, cognitive function, nutritional status and quality of life after the intervention. Adherence was >90 %, with no adverse events.

CONCLUSION

The LFN-exercise protocol improves portal hypertension, cerebral hemodynamics and cognitive function, as well as nutritional status and quality of life.

GOV NUMBER

NCT03932552.

摘要

背景

体育锻炼(PE)已被证明对肝硬化患者有益;但其对认知功能和脑血流动力学的影响尚待探索。

目的

评估 LFN-运动方案(LFN-exercise protocol)对肝/脑血流动力学的影响。

方法

对肝硬化患者进行随机开放临床试验;对照组:饮食(n = 13),干预组:饮食+运动(n = 14),共 12 周。患者接受教育课程、脑力锻炼(印刷书籍和数独)和高蛋白饮食。运动干预包括每周 4 次,强度在 Borg 量表上评分为 12-14 级,通过腕带加速度计进行监测。患者每周会收到鼓励坚持的短信,并每月进行一次面对面的访问。

结果

患者主要为 Child-Pugh A(88.9%),中位 MELD 8(8-10),平均年龄 53±8 岁。运动组的步数从 9667±3008 增加到 11931±4463(p = 0.002),而对照组从 8004±3224 增加到 8903±3504(p = 0.053)。运动组的 HVPG 从 11(8-14)mmHg 下降到 8(6-11)mmHg(p = 0.032),而对照组无变化,从 14(12-16)mmHg 增加到 15(11-17)mmHg(p = 0.959)。干预组在干预后显示出更好的脑血流动力学、认知功能、营养状况和生活质量。依从性>90%,无不良事件。

结论

LFN-运动方案可改善门静脉高压、脑血流动力学和认知功能,以及营养状况和生活质量。

GOV 编号:NCT03932552。

相似文献

1
Effect of a monitored exercise protocol in cerebral and hepatic hemodynamics in patients with cirrhosis and portal hypertension.监测运动方案对肝硬化和门静脉高压症患者脑血流和肝血流动力学的影响。
Dig Liver Dis. 2024 May;56(5):827-835. doi: 10.1016/j.dld.2023.11.011. Epub 2023 Nov 25.
2
Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.辛伐他汀降低肝硬化和门静脉高压患者的门静脉压力:一项随机对照试验。
Gastroenterology. 2009 May;136(5):1651-8. doi: 10.1053/j.gastro.2009.01.043. Epub 2009 Jan 24.
3
Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension.恩卡司他用于治疗非酒精性脂肪性肝炎相关肝硬化伴严重门静脉高压的随机安慰剂对照试验。
J Hepatol. 2020 May;72(5):885-895. doi: 10.1016/j.jhep.2019.12.010. Epub 2019 Dec 21.
4
Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension.体育锻炼会增加肝硬化和门静脉高压患者的门静脉压力。
Gastroenterology. 1996 Nov;111(5):1300-6. doi: 10.1053/gast.1996.v111.pm8898644.
5
A randomized study of losartan vs propranolol: Effects on hepatic and systemic hemodynamics in cirrhotic patients.氯沙坦与普萘洛尔的随机研究:对肝硬化患者肝脏及全身血流动力学的影响
Ann Hepatol. 2003 Jan-Mar;2(1):36-40.
6
Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.血管性血友病因子水平可预测肝硬化合并门静脉高压患者的临床结局。
Gut. 2011 Aug;60(8):1133-8. doi: 10.1136/gut.2010.235689. Epub 2011 Mar 22.
7
Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.非选择性β受体阻滞剂可改善晚期肝硬化患者肝硬度与门脉压力的相关性。
J Gastroenterol. 2012 May;47(5):561-8. doi: 10.1007/s00535-011-0517-4. Epub 2011 Dec 15.
8
Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study.沙丙蝶呤对肝硬化合并门静脉高压症患者门静脉和体循环血流动力学的影响:一项双中心、双盲、安慰剂对照研究。
Am J Gastroenterol. 2015 Jul;110(7):985-92. doi: 10.1038/ajg.2015.185. Epub 2015 Jun 16.
9
A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP).一项雷洛昔芬降低肝硬化患者门静脉压力的 2 期随机对照试验(STOPP)。
Trials. 2020 Mar 12;21(1):260. doi: 10.1186/s13063-020-4203-9.
10
Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score.肌肉减少症对肝硬化预后价值的影响:超越肝静脉压力梯度和 MELD 评分。
J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):860-870. doi: 10.1002/jcsm.12333.